ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Infection"

  • 2021 American Transplant Congress

    Evaluation of a Weight-Based Mycophenolate Mofetil Dosing Protocol for Kidney Transplant Maintenance Immunosuppression

    M. Mahoney1, E. Kincaide1, J. Nelson1, K. Klein1, R. Hall1, S. Bhayana2

    1University Health, San Antonio, Department of Pharmacotherapy and Pharmacy Services, The University of Texas at Austin, Pharmacotherapy Division, College of Pharmacy, San Antonio, TX, 2University Transplant Center, University Health, San Antonio, Department of Nephrology, The University of Texas Health Science Center at San Antonio, San Antonio, TX

    *Purpose: To evaluate the safety and efficacy of a weight-based mycophenolate mofetil (MMF) dosing protocol in adult kidney transplant recipients (KTR).*Methods: This single-center retrospective study…
  • 2021 American Transplant Congress

    Pulmonary Infections in Patients with Kidney Transplant: Epidemiology, Risk Factors and Impact of a Dedicated Pre-Transplant Infectious Disease Consultation

    E. Feredj

    Infectious Disease, APHP Henri Mondor, Créteil, France

    *Purpose: We aim to describe the spectrum of pulmonary infections after kidney transplant, to identify risk factors and to evaluate the impact of pre transplant…
  • 2021 American Transplant Congress

    Multi-drug Resistant Infections in Solid Organ Transplant Recipients, a New Era of Risk

    L. A. Morais, D. Reynoso, A. Lea, M. Mujtaba, S. Merwat, R. Kulkarni, J. Fair, M. Kueht

    University of Texas Medical Branch, Galveston, TX

    *Purpose: Antibiotic drug resistant organisms (DRO) [extended spectrum beta-lactamase (ESBL), vancomycin-resistant enterococcus (VRE), and carbapenem resistant bacteria (CRB)] are becoming more prevalent and pose a…
  • 2021 American Transplant Congress

    Methenamine for the Prevention of Recurrent UTIs Post-Renal Transplant

    A. Bigness1, S. Mohamed2, S. Mandala1, N. Khodieva2, K. Robichaux3, H. Mohammed1, J. Buggs4, A. Kumar1, A. Brueckner5, L. Bowman5

    1Morsani College of Medicine, University of South Florida, Tampa, FL, 2College of Public Health, University of South Florida, Tampa, FL, 3Honors College, University of South Florida, Tampa, FL, 4Transplant Surgery, Tampa General Hospital, Tampa, FL, 5Department of Pharmacology, Tampa General Hospital, Tampa, FL

    *Purpose: Urinary tract infections (UTIs) are a highly prevalent postoperative complication in kidney transplant recipients (KTRs), occurring in approximately 34% of patients. The common method…
  • 2021 American Transplant Congress

    Cytomegalovirus Infection Among Adult Kidney Transplant Recipients: Findings From the USRDS-medicare Linked Database Study

    A. Raval1, M. Ganz2, S. Alam2, Y. Tang1, C. Santos3

    1Merck & Co., Inc., Rahway, NJ, 2Evidera-PPD, Waltham, MA, 3Rush University Medical Center, Chicago, IL

    *Purpose: Cytomegalovirus infection (CMVi) is a frequent complication and significant cause of morbidity and mortality after kidney transplantation (KT). However, there are limited recent national…
  • 2021 American Transplant Congress

    Risk Factors for Mortality in Kidney Transplant Patients Infected by Sars-cov-2 in South of Spain

    V. Lopez1, T. Vazquez1, C. Casas1, I. Poveda2, J. Alonso1, D. Hernandez1

    1Nephrology, Nephrology Department, Hospital Regional Universitario de Málaga and University of Málaga, IBIMA, REDinREN (RD16/0009/0006), Málaga, Spain, Málaga, Spain, 2Nephrology, Nephrology Department, Hospital Torrecárdenas, Almería., Málaga, Spain

    *Purpose: Covid-19 pandemic has especially affected kidney transplant (KT) recipients, who are more vulnerable than the general population due to their immunosuppressive status and added…
  • 2021 American Transplant Congress

    Liver and Kidney Transplantation During the Covid-19 Pandemic Period: A Single Center Experience

    M. Haberal1, E. Karakaya1, A. Akdur1, E. Ayvazoglu Soy1, F. Ozcay2, E. Baskin3, S. Boyacioglu4, A. Torgay5, S. Yildirim1, G. Moray1, F. Yarbug Karakayali1

    1Division of Transplantation, Department of General Surgery, Baskent University, Ankara, Turkey, 2Department of Pediatric Gastroenterology, Baskent University, Ankara, Turkey, 3Department of Pediatric Nephrology, Baskent University, Ankara, Turkey, 4Department of Gastroenterology, Baskent University, Ankara, Turkey, 5Department of Anaesthesiology, Baskent University, Ankara, Turkey

    *Purpose: Introduction: Beginning of this year, when the Covid-19 pandemic has first started, it had the immediate effect of severely reducing living and deceased organ…
  • 2021 American Transplant Congress

    Propensity Matched Analysis of Death and Non-favorable Discharge Among Hospitalized Transplant Recipients with COVID-19

    J. T. Swan1, E. Rizk2, S. L. Jones1, N. Nwana1, J. C. Nicolas1, A. Tran1, T. Nisar1, T. Menser1, S. G. Yi2, L. W. Moore1, A. O. Gaber2, R. J. Knight2

    1Houston Methodist Research Institute, Houston, TX, 2Houston Methodist Hospital, Houston, TX

    *Purpose: This study compared death and non-favorable discharge following a hospital admission for Coronavirus Disease 2019 (COVID-19) management for patients with a history of solid…
  • 2021 American Transplant Congress

    T-Cell Exhaustion in EBV DNAemic Solid Organ Transplant Recipients

    S. Kothari, T. Ku, D. Kumar, A. Humar, V. H. Ferreira

    Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada

    *Purpose: In transplant recipients, disease severity after infection with Epstein-Barr virus (EBV) may range from asymptomatic DNAemia to PTLD. Host factors likely play a key…
  • 2021 American Transplant Congress

    Outcomes in High Risk CMV Liver Transplants with Elevated MELD Scores

    S. Freedman1, K. Saunders2, T. Sparkes1, B. Masters1, M. Plazak1, K. Saharia3, D. Maluf3, B. Ravichandran2

    1University of Maryland Medical Center, Baltimore, MD, 2University of Maryland School of Pharmacy, Baltimore, MD, 3University of Maryland School of Medicine, Baltimore, MD

    *Purpose: There is inconclusive evidence on the impact of MELD score on CMV viremia after liver transplantation. Following the implementation of Share 35, liver transplant…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 84
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences